LLY has been in the news 310% more than usual
Feb 07, 2026, 11:32 AM
-6.64%
What does LLY do
Eli Lilly & Co., headquartered in Indianapolis, employs 43,000 staff and develops various pharmaceutical products, including diabetes, oncology, immunology, and neuroscience therapies, alongside radiopharmaceuticals through its subsidiary POINT Biopharma. The company manufactures and distributes products in the U.S., Europe, and Asia.
LLY has been in the news recently: Eli Lilly & Company (LLY) shares rose about 3% on Friday after an earlier roughly 8% intraday decline amid a broader market rally. The move came as President Trump’s TrumpRx launch, low‑cost GLP‑1 offers from firms like Hims & Hers, and related legal and regulatory scrutiny intensified competition in the weight‑loss drug market that includes Lilly.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.